Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Archives

You are currently viewing the 2001 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Patents Expiring in May 2012

« Back to Dashboard
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Patented / Exclusive Use
Bristol Myers Squibb
SERZONE
nefazodone hydrochloride
Tablet; Oral020152DEC 22, 1994RXYes5,256,664<disabled>
Bristol Myers Squibb
SERZONE
nefazodone hydrochloride
Tablet; Oral020152DEC 22, 1994RXNo5,256,664<disabled>
Bristol Myers Squibb
SERZONE
nefazodone hydrochloride
Tablet; Oral020152DEC 22, 1994DISCNNo5,256,664<disabled>
Abbott
ZEMPLAR
paricalcitol
Injectable; Injection020819APR 17, 1998RXYes5,246,925<disabled>METHOD FOR TREATING HYPERPARATHYROIDISM WHICH COMPRISES SUPPRESSING PARATHYROID ACTIVITY
Glaxo Wellcome
TRITEC
ranitidine bismuth citrate
Tablet; Oral020559AUG 08, 1996DISCNNo5,407,688<disabled>METHOD OF TREATING GI DISORDERS COMPRISING ADMINISTRATION OF CAMPYLOBACTER-INHIBITING ANTIMICROBIAL AGENT AND H2 RECEPTOR BLOCKING ANTI-SECRETORY AGENT
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc